LENZ Therapeutics, Inc. (LENZ) earnings
LENZ earnings moved a median of -1.23% by the close. Quarterly and annual LENZ reports and results, each read against the price at its own news timestamp. Back to the LENZ overview →
24 measured LENZ earnings events.
Where these LENZ earnings landedvs 24 measured LENZ earnings reactions
| Middle 50% of LENZ earnings reactions | -4.67% to +3.38% |
|---|---|
| Median reaction (to close) | -1.23% |
| Measured reactions | 24 |
Point-in-time · zero look-ahead
Half of the 24 LENZ earnings events with a measured close landed between -4.67% and +3.38%; 46% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q LENZ Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +9.35% | -15.86% | |
| LENZ Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights | Press release | +9.35% | -15.86% | |
| LENZ Therapeutics to Report Second Quarter 2026 Financial Results and Recent Corporate Highlights on August 11, 2026 | Press release | +0.78% | +3.33% | |
| Form 10-Q LENZ Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +3.43% | +4.22% | |
| LENZ Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights | Press release | +3.43% | +4.22% | |
| LENZ Therapeutics to Report First Quarter 2026 Financial Results and Recent Corporate Highlights on May 11, 2026 and Attend Upcoming Investor Conference | Press release | +2.87% | +4.39% | |
| Form 10-K LENZ Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.98% | -1.31% | |
| LENZ Therapeutics Reports Fourth Quarter 2025 Preliminary Unaudited Financial Results and Recent Corporate Updates | Press release | +0.92% | -6.79% | |
| Form 10-Q LENZ Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +1.94% | +3.52% | |
| LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights | Press release | -2.13% | -15.47% | |
| LENZ Therapeutics to Report Third Quarter 2025 Financial Results and Recent Corporate Highlights on November 5, 2025 | Press release | +0.39% | -1.16% | |
| Form 10-Q LENZ Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.18% | -2.55% | |
| LENZ Therapeutics Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights | Press release | -0.38% | -3.54% | |
| Form 10-Q LENZ Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +2.80% | +2.09% | |
| LENZ Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights | Press release | +2.80% | +2.09% | |
| LENZ Therapeutics to Report First Quarter 2025 Financial Results and Recent Corporate Highlights on May 7th, 2025 | Press release | -2.15% | +1.62% | |
| Form 10-K LENZ Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | -5.06% | -4.61% | |
| Form 10-Q LENZ Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.62% | +10.72% | |
| LENZ Therapeutics Reports Third Quarter 2024 Financial Results | Press release | -0.62% | +10.72% | |
| Form 10-Q LENZ Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.98% | -4.84% | |
| LENZ Therapeutics Reports Second Quarter 2024 Financial Results | Press release | -2.98% | -4.84% | |
| LENZ Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024 | Press release | -2.05% | +2.81% | |
| Form 10-Q LENZ Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.00% | -3.27% | |
| LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates | Press release | -1.00% | -3.27% |
Keep exploring
More LENZ: analyst actions → · SEC filings → · LENZ overview →